GAS5 and neoplasm: A 2018 paper by Avgeris M. et al. reported that patients with reduced lncRNA-GAS5 expression in tumour-lesioned tissues showed significantly shorter PFS (HR = 6.628; 95% CI: 1.494–29.40; p = 0.013).